Priority Healthcare b (NASDAQ:PHCC)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Priority Healthcare b Charts. Click Here for more Priority Healthcare b Charts.](/p.php?pid=staticchart&s=N%5EPHCC&p=8&t=15)
Priority Healthcare Corporation Acquires Partners in Care
Pharmacy, a Midwestern Infertility Specialty Pharmacy
LAKE MARY, Fla., April 5 /PRNewswire-FirstCall/ -- Priority Healthcare
Corporation today acquired certain assets of Partners In Care Pharmacy, an
infertility specialty pharmacy with a strong presence in the Midwest.
"The acquisition of Partners In Care adds additional volume to Priority
Healthcare's industry leading infertility specialty pharmacy business. It will
also enable us to leverage our infrastructure to serve a greater number of
infertility specialists and their patients," said Steve Cosler, President and
Chief Executive Officer of Priority Healthcare.
Partners in Care will be consolidated into PriorityHealthcare's national
Freedom Drug operations that are based in Byfield, MA. Freedom Drug is the
nation's leading provider of specialty pharmacy services for infertility. The
company's pioneering approach to expert infertility care, known as the Freedom
Advantage, offers a range of clinical and financial benefits for patients and
physicians that include 24-hour support and services. Freedom Drug also offers
payors a range of services through its innovative waste management programs.
Additional information for patients, physicians, and healthcare partners is
available at http://www.freedomdrug.com/
"Partners in Care generated sales of approximately $12 million in the past 12
months. This acquisition should be accretive in the second half of 2004," added
Steve Saft, Chief Financial Officer of Priority Healthcare.
About Priority Healthcare Corporation
Priority Healthcare Corporation is a national specialty pharmacy and distributor
that provides biopharmaceuticals, complex therapies, and related disease
treatment services. Priority Healthcare provides comprehensive programs for
patients, payors, physicians, and pharmaceutical manufacturers for a growing
number of disease states including cancer, hepatitis C, respiratory and
pulmonary conditions, infertility, rheumatoid arthritis, hemophilia, multiple
sclerosis, and macular degeneration. Additional information regarding Priority
Healthcare is available online at http://www.priorityhealthcare.com/
Certain statements included in this pressrelease, which are not historical
facts, are forward-looking statements. Such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements represent our expectations
or beliefs and involve certain risks and uncertainties, including those
described in our public filings with the United States Securities and Exchange
Commission; also including, but not limited to, changes in interest rates,
competitive pressures, changes in customer mix, changes in third party
reimbursement rates, financial stability of major customers, changes in
government regulations or the interpretation of these regulations, changes in
supplier relationships, growth opportunities, cost savings, revenue
enhancements, synergies and other benefits anticipated from acquisition
transactions, difficulties relative to integrating acquired businesses, the
accounting and tax treatment of acquisitions, and asserted and unasserted
claims, which could cause actual results to differ from those in the
forward-looking statements. The forward-looking statements by their nature
involve substantial risks and uncertainties, certain of which are beyond our
control, and actual results may differ materially depending on a variety of
important factors. You are cautioned not to place undue reliance on these
forward-looking statements that speak only as of the date herein.
Logo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20030417/PHCLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
DATASOURCE: Priority Healthcare Corporation
CONTACT: Investors, Stephen Saft, Chief Financial Officer,
+1-407-804-6700, or Media, Kirsten Ayars, Public Relations Manager,
+1-407-804-5826, both of Priority Healthcare Corporation
Web site: http://www.priorityhealthcare.com/
http://www.freedomdrug.com/